| 摘要 |
The present invention is directed to a composition of material for treating a patient susceptible to or suffering from either congestive heart failure, stroke, vascular dysfunction, hypertension, smooth muscle cell hypertrophy, platelet disorder cerebrovascular ischemia, or peripheral vascular ischemia, said composition comprising a therapeutically effective amount of a first substance selected from the group comprising either heparin, heparin sulfate, heparan, taprostene, prostacyclin, or physiologically acceptable salts thereof and therapeutically effective amount of a second substance selected from a group comprising either arginine, L-arginine, arginine sulfate, or physiologically acceptable salts thereof. |
